1 enrolling by invitation. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Enrolling by invitation 1 |
Follow Anticoagulant-induced Bleeding: new trials by email Literature Review of Anticoagulant-induced Bleeding trials Research Report on Anticoagulant-induced Bleeding
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology Aspirin 325mg, Enoxaparin 40Mg/0.4mL Prefilled Syringe - Sarcoma, Soft Tissue Sarcoma | Phase 4 | Enrolling by invitation | Massachusetts General Hospital | 2868 | 2018-02-16 | 2026-10-09 |
Bone Neoplasms (1) · Hematoma (1) · Sarcoma (1) · Venous Thromboembolism (1)
Bone Diseases (1) · Cardiovascular Diseases (1) · Embolism and Thrombosis (1) · Hemorrhage (1) · Musculoskeletal Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Connective and Soft Tissue (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Thromboembolism (1) · Vascular Diseases (1)
Aspirin (1) · Enoxaparin (1)
Massachusetts General Hospital (1)
United States (1)